Released: April 15, 2013
DEPARTMENT OF DEFENSE TUBEROUS SCLEROSIS COMPLEX RESEARCH PROGRAM
FISCAL YEAR 2013
The Fiscal Year 2013 (FY13) Defense Appropriations Act provides $6 million to the Department of Defense Tuberous Sclerosis Research Program (TSCRP). This program is administered by the US Army Medical Research and Materiel Command through the Office of the Congressionally Directed Medical Research Programs (CDMRP).
The TSCRP is providing the information in this pre-announcement to allow time to plan and develop applications. FY13 TSCRP program announcements and general application instructions for the following award mechanisms are anticipated to be posted on Grants.gov in May 2013. This pre-announcement should not be construed as an obligation by the government.
Areas of Focus: The FY13 TSCRP encourages research projects applications that specifically address the critical needs of the TSC community in the following areas of focus:
- Genetic, epigenetic, and non-genetic modifiers of TSC.
- Identification and development of preclinical models and therapeutic strategies (e.g., cytotoxic agents, combination therapies).
- Identifying biomarkers for early detection, prognosis, and prediction of treatment outcomes (such as serum markers, imaging, electrophysiology, prenatal testing, and pharmacogenetics).
- Impact of TSC manifestations in adults (e.g., care management, age-specific pathogenesis, epidemiology, renal, reproductive issues, and lymphangioleiomyomatosis [LAM])).
- Long-term benefits and effects of mTOR inhibitors or other agents.
- Novel strategies for diagnosis, treatment, and prevention of TSC manifestations including those geared toward early identification and intervention.
- Understanding the cellular and molecular mechanisms of TSC and LAM pathogenesis.
- Understanding the mechanism and improving the treatment of epilepsy in TSC.
- Understanding the mechanism and improving treatment of TSC-associated neurocognitive disorders (TAND) including cognitive impairment, and psychiatric, behavioral, and sleep disorders.
|Award Mechanism||Eligibility||Key Mechanism Elements||Funding|
|Pilot Clinical Trial Award||Must be an independent investigator at or above the level of Assistant Professor (or equivalent)||
|Exploration -Hypothesis Development Award||Investigators at all academic levels (or equivalent)||
|Idea Development Award||Independent investigators with a documented faculty appointment (or equivalent)||
All applications must conform to the final program announcements and general application instructions that will be available for electronic downloading from the Grants.gov website upon official announcement of funding opportunity release. Submission deadlines will not be available until the program announcements are released. Requests for email notification of the program announcements release may be sent to firstname.lastname@example.org. For more information about the TSCRP or other CDMRP-administered programs, please visit the CDMRP website (https://cdmrp.army.mil).
Point of Contact:
- CDMRP Public Affairs